Myeloid cell‐derived NLRP3 is dispensable for silica‐induced pulmonary inflammation and pathology
- 20 November 2025
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 104 (1) , 20-34
Abstract
Silicosis is a progressive occupational lung disease marked by persistent silica‐induced inflammation and irreversible pulmonary fibrosis. The NLRP3 inflammasome, an innate immune sensor, has been implicated as a key driver of silica‐triggered inflammation and fibrosis in preclinical models. However, the specific role of NLRP3 in immune cells, particularly within myeloid cells (monocytes, macrophages and neutrophils), remains poorly defined. In this study, we investigated the in vivo contribution of myeloid‐derived NLRP3 to silica‐induced lung pathology using a conditional NLRP3 knockout mouse model ( LysM Cre Nlrp 3 fl/fl ). These mice exhibited efficient deletion of NLRP3 in both resident and infiltrating lung myeloid cells. Following intranasal delivery of 2 mg of silica, NLRP3 expression was upregulated in myeloid cells by day 3. Despite upregulation of NLRP3 in myeloid cells by day 3, early inflammasome activation in the tissue and BAL, including caspase‐1 cleavage and IL‐1β and IL‐18 secretion, remained intact. During the chronic phase (days 14 and 28), myeloid NLRP3 deletion did not mitigate hallmark features of silicosis, including alveolitis, structural lung damage, airway remodeling or peribronchial alpha‐smooth muscle actin expression. Furthermore, the formation and size of silicotic nodules were unaffected. These findings indicate that NLRP3 expression in myeloid cells is not essential for the development of silica‐induced pulmonary inflammation, tissue damage or fibrosis. This work highlights the need to explore alternative cellular sources and mechanisms of NLRP3‐driven pathology in silicosis.Keywords
This publication has 50 references indexed in Scilit:
- NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblastsBiochemical Pharmacology, 2024
- A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseasesClinical & Translational Immunology, 2023
- Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine SteatohepatitisCellular and Molecular Gastroenterology and Hepatology, 2022
- Necroptosis in pulmonary macrophages promotes silica-induced inflammation and interstitial fibrosis in miceToxicology Letters, 2022
- PM2.5-induced lung injury is attenuated in macrophage-specific NLRP3 deficient miceEcotoxicology and Environmental Safety, 2021
- Silica particles disorganize the polarization of pulmonary macrophages in miceEcotoxicology and Environmental Safety, 2020
- Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity and chronic lung disease following silica exposureToxicology and Applied Pharmacology, 2016
- Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter miceJournal of Immunological Methods, 2014
- Silica phagocytosis causes apoptosis and necrosis by different temporal and molecular pathways in alveolar macrophagesApoptosis, 2013
- Differences in cellular and inflammatory cytokine profiles in the bronchoalveolar lavage fluid in bagassosis and silicosisAmerican Journal of Industrial Medicine, 2004